Probiotic developer Synbiotic Health acquires new facility in Madison, Wisconsin
The facility is expected to be operational in early 2023.
Probiotic developer Synbiotic Health (Lincoln, NE) has acquired a new facility in Madison, WI. The 43,000-sq-ft facility is expected to be operational in early 2023 and will focus on “scale-up and development of efficient commercial processes.”
The company’s existing facilities in Lincoln, NE, focus on discovering new probiotic strains. The new Madison facility “is being constructed specifically to support probiotics in a quality-focused GMP environment that features very low humidity levels in all areas where probiotic ingredients will be found,” the company says in a press release. “New lab space, which will have the capacity to accommodate numerous scientists, will allow Synbiotic Health to quickly screen new probiotics for growth and stability, thus increasing the company’s ability to introduce new, high-quality strains to the market.”
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
